You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

anti-IL-17

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Axial Spondyloarthritis Trial in Nîmes, Montpellier, Tours (Daily dietary supplementation with Fibruline, Anti-IL-17 therapy)

Recruiting
  • Axial Spondyloarthritis
  • Daily dietary supplementation with Fibruline
  • Anti-IL-17 therapy
  • Nîmes, Gard, France
  • +2 more
Apr 19, 2023

Psoriasis Trial in Shanghai, Kunming (Recombinant Anti-IL-17A Humanized Monoclonal Antibody Injection, Placebo)

Active, not recruiting
  • Psoriasis
  • Recombinant Anti-IL-17A Humanized Monoclonal Antibody Injection
  • Placebo
  • Shanghai, Shanghai, China
  • +2 more
Nov 7, 2022

Psoriasis Trial in Shanghai (608 Q2W, 608 Q4W, Placebo)

Not yet recruiting
  • Psoriasis
  • 608 Q2W
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Huanshan Hospital Fudan University
Sep 8, 2022

Axial Spondyloarthritis Trial in Besançon (Blood sample, anti-TNF antibody administration, anti-IL-17 antibody administration)

Recruiting
  • Axial Spondyloarthritis
  • Blood sample
  • +2 more
  • Besançon, France
    Centre Hospitalier Universitaire de Besançon
May 31, 2022

Autoimmune Disease Trial in Joondalup, Nedlands (SCT650C)

Not yet recruiting
  • Autoimmune Disease
  • Joondalup, Western Australia, Australia
  • +2 more
Jun 7, 2023

Type1 Diabetes Trial in Sweden (Ixekizumab, Placebo)

Recruiting
  • Type1 Diabetes Mellitus
  • Borås, Sweden
  • +17 more
Dec 5, 2022

Psoriatic Arthritis Trial in Minsk, Chelyabinsk, Saint-Petersburg (BCD-085, Placebo)

Active, not recruiting
  • Psoriatic Arthritis
  • Minsk, Belarus
  • +2 more
Sep 6, 2021

Polymyalgia Rheumatica, Inflammatory Diseases Trial in Worldwide (AIN457, ACZ885, Prednisone)

Terminated
Has Results
  • Polymyalgia Rheumatica
  • Inflammatory Diseases
  • Rochester, Minnesota
  • +5 more
Aug 17, 2021

Plus Serum Levels of IL23 and IL17A to Rheumatoid Arthritis

Not yet recruiting
  • Rheumatoid Arthritis
    • (no location specified)
    Oct 4, 2022

    Patients Receiving Biotherapies Targeting IL-23/IL-17 Axis in

    Recruiting
    • Psoriasis
    • Blood sample
    • +2 more
    • Paris, Ile De France, France
      Lars ROGGE
    Oct 6, 2022

    Crohn's Disease, Inflammatory Bowel Disease Trial in United States (AIN457)

    Terminated
    Has Results
    • Crohn's Disease
    • Inflammatory Bowel Disease
    • Bristol, Connecticut
    • +4 more
    Jun 18, 2021

    Host Microbiota and Il-17 in Favoring Multiple Myeloma

    Recruiting
    • Multiple Myeloma
      • Milan, Milano, Italy
        IRCCS Ospedale San Raffaele
      Jan 26, 2023

      Acne Vulgaris, Vitamin D Trial in Jakarta Pusat (combination oral and topical vitamin D, oral and topical cholecalciferol, oral

      Enrolling by invitation
      • Acne Vulgaris
      • Vitamin D
      • combination oral and topical vitamin D
      • +2 more
      • Jakarta Pusat, DKI Jakarta, Indonesia
        RSUPN Dr. Cipto Mangunkusumo
      Mar 4, 2023

      Pyoderma Gangrenosum Trial in Munich (Secukinumab)

      Unknown status
      • Pyoderma Gangrenosum
      • Munich, Germany
        Technical University of Munich
      Feb 17, 2020

      Crohn Disease Trial in Calgary (TNFa Antagonist - Infliximab, TNFa Antagonist - Adalimumab, Anti-IL12/23 or anti-IL23 -

      Not yet recruiting
      • Crohn Disease
      • TNFa Antagonist - Infliximab
      • +5 more
      • Calgary, Alberta, Canada
        University of Calgary
      Jun 22, 2023

      Acute Gout Trial in Wuhan, Linyi, Shanghai (Recombinant Anti-IL-1ß Humanized Monoclonal Antibody Injection 100 mg (phase Ib),

      Recruiting
      • Acute Gout
      • Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection 100 mg (phase Ib)
      • +6 more
      • Wuhan, Hubei, China
      • +2 more
      Oct 17, 2022

      IL17 Rate and Spondyloarthritis

      Recruiting
      • Spondylarthritis
      • Blood sample
      • Nice, France
        CHU de NICE
      Oct 21, 2022

      Periodontitis Trial (No intervention was applied to the groups the samples will be collected in terms of the diagnosis

      Not yet recruiting
      • Periodontitis
      • No intervention was applied to the groups the samples will be collected in terms of the diagnosis (periodontitis, healthy)
      • (no location specified)
      Mar 31, 2022

      Non-Eosinophilic Biological Effects of IL-5

      Not yet recruiting
      • Asthma
        • (no location specified)
        Sep 6, 2023

        Il-17 and Il-18 in Aggressive Periodontitis

        Completed
        • Aggressive Periodontitis
        • non surgical periodontal therapy
        • Cairo, Egypt
          Faculty of oral and dental medicine,FUE, Cairo,Egypt
        Mar 30, 2022

        COVID-19 Respiratory Infection Trial in Sohag (laboratory test)

        Completed
        • COVID-19 Respiratory Infection
        • laboratory test
        • Sohag, Egypt
          Sohag University
        Oct 24, 2022

        Esophagus Cancer, Bladder Cancer, Liver Cancer Trial (Intravenous injection of P-IL-2, P-IL-2 plus Anti-PD-1 Monoclonal

        Not yet recruiting
        • Esophagus Cancer
        • +4 more
        • Intravenous injection of P-IL-2
        • P-IL-2 plus Anti-PD-1 Monoclonal Antibody
        • (no location specified)
        Apr 24, 2023

        LAD1 Trial run by the NIAID (Ustekinumab)

        Recruiting
        • LAD1
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 24, 2023

        Periodontitis, Periodontal Diseases, Smoking Trial in Ankara (Non-surgical periodontal treatment)

        Completed
        • Periodontitis
        • +3 more
        • Non-surgical periodontal treatment
        • Ankara, Turkey
        • +1 more
        Mar 15, 2022

        Active Ankylosing Spondylitis Trial in China (JS005, Placebo)

        Recruiting
        • Active Ankylosing Spondylitis
        • JS005
        • Placebo
        • Hefei, Anhui, China
        • +22 more
        Jan 23, 2022